Understanding processes in the development and manufacture of biological drug substances is crucial to successfully navigating the clinical phases towards commercial launch, all within ever‑tightening time constraints, and regulatory frameworks.
Danielle Wittenwyler
Advertisement
Danielle Wittenwyler, PhD, is manager, Manufacturing Science & Technology, Catalent Biologics.
Articles by Danielle Wittenwyler
Advertisement
Latest Updated Articles
Advertisement
Advertisement